162 related articles for article (PubMed ID: 9356496)
1. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.
Cooper AJ; Sheu KR; Burke JR; Onodera O; Strittmatter WJ; Roses AD; Blass JP
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12604-9. PubMed ID: 9356496
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats.
Ruoppolo M; Orrù S; Francese S; Caputo I; Esposito C
Protein Sci; 2003 Jan; 12(1):170-9. PubMed ID: 12493840
[TBL] [Abstract][Full Text] [Related]
3. Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases.
Gentile V; Sepe C; Calvani M; Melone MA; Cotrufo R; Cooper AJ; Blass JP; Peluso G
Arch Biochem Biophys; 1998 Apr; 352(2):314-21. PubMed ID: 9587422
[TBL] [Abstract][Full Text] [Related]
4. Polyglutamine domains are substrates of tissue transglutaminase: does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases?
Cooper AJ; Sheu KF; Burke JR; Onodera O; Strittmatter WJ; Roses AD; Blass JP
J Neurochem; 1997 Jul; 69(1):431-4. PubMed ID: 9202340
[TBL] [Abstract][Full Text] [Related]
5. Lysine-rich histone (H1) is a lysyl substrate of tissue transglutaminase: possible involvement of transglutaminase in the formation of nuclear aggregates in (CAG)(n)/Q(n) expansion diseases.
Cooper AJ; Wang J; Pasternack R; Fuchsbauer HL; Sheu RK; Blass JP
Dev Neurosci; 2000; 22(5-6):404-17. PubMed ID: 11111157
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability.
Cooper AJ; Sheu KF; Burke JR; Strittmatter WJ; Gentile V; Peluso G; Blass JP
J Neurochem; 1999 Mar; 72(3):889-99. PubMed ID: 10037459
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of α-ketoglutarate-and pyruvate dehydrogenase complexes in E. coli by a glutathione S-transferase containing a pathological length poly-Q domain: A possible role of energy deficit in neurological diseases associated with poly-Q expansions?
Cooper AJ; Sheu KF; Burke JR; Onodera O; Strittmatter WJ; Roses AD; Blass JP
Age (Omaha); 1998 Jan; 21(1):25-30. PubMed ID: 23604331
[TBL] [Abstract][Full Text] [Related]
8. Identification of amine acceptor protein substrates of transglutaminase in liver extracts: use of 5-(biotinamido) pentylamine as a probe.
Ikura K; Kita K; Fujita I; Hashimoto H; Kawabata N
Arch Biochem Biophys; 1998 Aug; 356(2):280-6. PubMed ID: 9705218
[TBL] [Abstract][Full Text] [Related]
9. Identification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenase.
Orru S; Ruoppolo M; Francese S; Vitagliano L; Marino G; Esposito C
Protein Sci; 2002 Jan; 11(1):137-46. PubMed ID: 11742130
[TBL] [Abstract][Full Text] [Related]
10. Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases?
Cooper AJ; Jeitner TM; Gentile V; Blass JP
Neurochem Int; 2002 Jan; 40(1):53-67. PubMed ID: 11738472
[TBL] [Abstract][Full Text] [Related]
11. α-Ketoglutarate dehydrogenase complex moonlighting: ROS signalling added to the list: An Editorial highlight for 'Reductions in the mitochondrial enzyme α-ketoglutarate dehydrogenase complex in neurodegenerative disease - beneficial or detrimental?'.
Fernandez E; Bolaños JP
J Neurochem; 2016 Dec; 139(5):689-690. PubMed ID: 27882614
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of alpha-ketoglutarate dehydrogenase during enzyme-catalyzed reaction.
Bunik VI; Romash OG; Gomazkova VS
Biochem Int; 1990 Dec; 22(6):967-76. PubMed ID: 2090109
[TBL] [Abstract][Full Text] [Related]
13. Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking.
Konno T; Morii T; Hirata A; Sato S; Oiki S; Ikura K
Biochemistry; 2005 Feb; 44(6):2072-9. PubMed ID: 15697232
[TBL] [Abstract][Full Text] [Related]
14. The glyceraldehyde-3-phosphate dehydrogenase binds in vitro to the SH3 domain of Saccharomyces cerevisiae Cdc25p.
Buu A; Garreau H; Jacquet M
C R Acad Sci III; 1995 Jun; 318(6):665-9. PubMed ID: 7671010
[TBL] [Abstract][Full Text] [Related]
15. [Regulation of cooperative properties of alpha-ketoglutarate dehydrogenase by means of thiol-disulfide metabolism].
Bunik VI; Buneeva OA; Gomazkova VS
Biokhimiia; 1991 Apr; 56(4):694-706. PubMed ID: 1912072
[TBL] [Abstract][Full Text] [Related]
16. Substrates of hexokinase, glucose-6-phosphate dehydrogenase, and glyceraldehyde-3-phosphate dehydrogenase prevent the inhibitory response induced by ascorbic acid/iron and dehydroascorbic acid in rabbit erythrocytes.
Fiorani M; De Sanctis R; Scarlatti F; Stocchi V
Arch Biochem Biophys; 1998 Aug; 356(2):159-66. PubMed ID: 9705206
[TBL] [Abstract][Full Text] [Related]
17. The non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase: biochemistry, structure, occurrence and evolution.
Habenicht A
Biol Chem; 1997 Dec; 378(12):1413-9. PubMed ID: 9461340
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
De Vivo G; Gentile V
CNS Neurol Disord Drug Targets; 2008 Oct; 7(4):370-5. PubMed ID: 18991665
[TBL] [Abstract][Full Text] [Related]
19. 4-Hydroxy-2(E)-nonenal enantiomers: (S)-selective inactivation of glyceraldehyde-3-phosphate dehydrogenase and detoxification by rat glutathione S-transferase A4-4.
Hiratsuka A; Hirose K; Saito H; Watabe T
Biochem J; 2000 Aug; 349 Pt 3(Pt 3):729-35. PubMed ID: 10903133
[TBL] [Abstract][Full Text] [Related]
20. Mapping of the interaction site of CP12 with glyceraldehyde-3-phosphate dehydrogenase from Chlamydomonas reinhardtii. Functional consequences for glyceraldehyde-3-phosphate dehydrogenase.
Lebreton S; Andreescu S; Graciet E; Gontero B
FEBS J; 2006 Jul; 273(14):3358-69. PubMed ID: 16803460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
